$0.30 -0.01 (%) Hemispherx Biopharma Inc - AMEX

Oct. 22, 2014 | 03:59 PM

Partner Headlines

  1. Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola

    Benzinga | Oct. 20, 2014 | 12:01PM EST
  2. Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear

    IBD | Oct. 9, 2014 | 14:38PM EST
  3. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga | Oct. 8, 2014 | 13:04PM EST
  4. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga | Oct. 6, 2014 | 14:08PM EST
  5. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD | Oct. 1, 2014 | 14:20PM EST
  6. UPDATE: Hemispherx Biopharma Formally Collaborates With the Swiss Department of Defense, Civil Protection and Sports to Study Alferon(R) Against Tamiflu Resistant Influenza Virus Strains

    Benzinga | May. 14, 2014 | 08:35AM EST
  7. Hemisphrex Announces Publication of Ampligen Safety Profile Across Diverse Animal Species

    Benzinga | Apr. 8, 2014 | 08:35AM EST
  8. Hemispherx Shares Jump 13+% Following Release of Summarized Phase 1/2 Data on Flu Combo

    Benzinga | Feb. 4, 2014 | 08:49AM EST
  9. Hemispherx Announces Alpha-N3 is Active Compared to Two H7N9 Virus Types

    Benzinga | Sep. 12, 2013 | 08:04AM EST
  10. Hemispherx Reports Biosecurity Program for Reduction of Pandemic Flu Threat

    Benzinga | Sep. 12, 2013 | 07:31AM EST
  11. Hemispherx Reports Biosecurity Program to Potentially Reduce Pandemic Flu Threat

    Benzinga | Aug. 26, 2013 | 08:04AM EST
  12. Hemispherx Biopharma Says FDA Panel Voted 9-4 Against Ampligen Effocacy

    Benzinga | Dec. 21, 2012 | 08:00AM EST
  13. Hemispherx BioPharma Soars Then Plunges as FDA Panel Votes Against Ampligen Approval

    Benzinga | Dec. 20, 2012 | 11:09AM EST
  14. FDA Issues Review of Hemispherx's Ampligen Lacks Required Carcinogencity Tests

    Benzinga | Dec. 18, 2012 | 01:07AM EST
  15. Hemispherx Biopharma Inc Reports Operating Results (10-Q)

    GuruFocus | Nov. 2, 2012 | 11:07AM EST
  16. Hemispherx Biopharma Says FDA Will Review Ampligen December 20

    Benzinga | Oct. 22, 2012 | 02:51AM EST
  17. Earnings Scheduled For October 10, 2012

    Benzinga | Oct. 9, 2012 | 20:32PM EST
  18. Benzinga's Microcap Movers for Thursday September 20, 2012

    Benzinga | Sep. 20, 2012 | 13:56PM EST
  19. Top Narrow Based Indexes For September 18

    Benzinga | Sep. 18, 2012 | 05:03AM EST
  20. Benzinga's Microcap Movers for Thursday August 23, 2012

    Benzinga | Aug. 23, 2012 | 14:24PM EST
  21. Cirrus Logic, Synopsys Among Stocks Setting 52-Week Highs Thursday

    FoxBusiness | Aug. 23, 2012 | 06:32AM EST
  22. Michael Kors Holdings, Velti Among Stocks Gapping Up Tuesday

    FoxBusiness | Aug. 14, 2012 | 04:30AM EST
  23. Hemispherx Biopharma Inc Reports Operating Results (10-Q)

    GuruFocus | Aug. 8, 2012 | 11:24AM EST
  24. Hemispherx Biopharma Announces Filing a New Drug Application in Argentina for Ampligen to Treat Chronic Fatigue Syndrome

    Benzinga | Jul. 18, 2012 | 02:06AM EST
  25. Benzinga's Microcap Movers for Thursday January 26, 2012

    Benzinga | Jan. 26, 2012 | 15:18PM EST
  26. Swine Flu Outbreak in Mexico Sends Small BioPharma Sky-High

    Benzinga | Jan. 23, 2012 | 04:20AM EST
  27. Oink Oink: Profit From The Return Of Swine Flu

    Benzinga | Jan. 12, 2012 | 06:40AM EST
  28. Benzinga's Microcap Movers for Wednesday January 11, 2012

    Benzinga | Jan. 11, 2012 | 13:23PM EST
  29. BoardCentral StockTalk - weekly update: AAPL, BRKA, AMD, WNBD, HEB, CTIC, SPY, AAPL, GOOG, more...

    BoardCentral | Jul. 9, 2011 | 23:55PM EST
Trading Center